Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

Anti-infection

Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.

Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.

Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.

Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.

Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.

Items 1711-1719 of 1719

Page
per page
  1. (+)-Ofloxacin
    C8735 (+)-Ofloxacin
    Summary: The R-enantiomer of the fluoroquinolone antibacterial drug ofloxacin; forms a complex by binding bacterial DNA and DNA topoisomerase II (DNA gyrase), inhibiting DNA strand annealing and bacterial replication
      insoluble in DMSO; insoluble in EtOH; ≥25.35 mg/mL
  2. 8-Epidiosbulbin E acetate
    N2890 8-Epidiosbulbin E acetate
    Summary: A furan compound with broad-spectrum plasmid-curing activity against multiple multidrug-resistant bacteria, including vancomycin-resistant enterococci
      ≥50.5 mg/mL
  3. Doxycycline hydrochloride
    C8734 Doxycycline hydrochloride
    Summary: A broad-spectrum tetracycline antibiotic that primarily inhibits the bacterial ribosomal 30S subunit, thereby blocking protein synthesis
  4. Hexadecanamide
    N2889 Hexadecanamide
    Summary: A fatty acid amide derived from palmitic acid, commonly used to study its anti-inflammatory and neuroprotective effects
      ≥4.46 mg/mL
  5. Pentoxifylline
    C3816 Pentoxifylline
    Summary: A phosphodiesterase (PDE, especially PDE IV) inhibitor
  6. Amikacin Sulfate
    C8696 Amikacin Sulfate
    Summary: An aminoglycoside antibiotic that exerts dose-dependent bactericidal activity mainly against Mycobacterium avium (Mycobacterium avium, MAC) and Staphylococcus aureus (Staphylococcus aureus).
  7. Ceftolozane sulfate
    C8753 Ceftolozane sulfate
    Summary: A time-dependent oxyimino cephalosporin antibacterial agent that inhibits bacterial penicillin-binding proteins (PBP3 as the primary target).
  8. KR-12 (human) TFA
    C8754 KR-12 (human) TFA
    Summary: The smallest antimicrobial active fragment of the human antimicrobial peptide LL-37 (corresponding to amino acids 18–29 of LL-37)
  9. Eflornithine hydrochloride
    C8761 Eflornithine hydrochloride
    Summary: An irreversible ornithine decarboxylase (ODC) inhibitor

Items 1711-1719 of 1719

Page
per page